| Monoclonal antibodies: a review S Singh, NK Tank, P Dwiwedi, J Charan, R Kaur, P Sidhu, VK Chugh Current clinical pharmacology 13 (2), 85-99, 2018 | 384 | 2018 |
| Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease … ML Ferreira, K De Luca, LM Haile, JD Steinmetz, GT Culbreth, M Cross, ... The Lancet Rheumatology 5 (6), e316-e329, 2023 | 291 | 2023 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 268 | 2022 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 247 | 2021 |
| Endocannabinoid system: a multi-facet therapeutic target R Kaur, S R Ambwani, S Singh Current clinical pharmacology 11 (2), 110-117, 2016 | 164 | 2016 |
| Cardiovascular adverse events reported from COVID-19 vaccines: a study based on WHO database R Jeet Kaur, S Dutta, J Charan, P Bhardwaj, A Tandon, D Yadav, S Islam, ... International journal of general medicine, 3909-3927, 2021 | 128 | 2021 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet Infectious Diseases 22 (11), 1626-1647, 2022 | 112 | 2022 |
| What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials R Kaur, P Sidhu, S Singh Journal of Pharmacology and Pharmacotherapeutics 7 (3), 120-126, 2016 | 95 | 2016 |
| Use of complementary and alternative medicine (CAM) and home remedies by COVID-19 patients: a telephonic survey J Charan, P Bhardwaj, S Dutta, R Kaur, SK Bist, MD Detha, T Kanchan, ... Indian Journal of Clinical Biochemistry 36, 108-111, 2021 | 87 | 2021 |
| Favipiravir use in COVID-19: analysis of suspected adverse drug events reported in the WHO database RJ Kaur, J Charan, S Dutta, P Sharma, P Bhardwaj, P Sharma, H Lugova, ... Infection and drug resistance, 4427-4438, 2020 | 85 | 2020 |
| Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications J Charan, RJ Kaur, P Bhardwaj, M Haque, P Sharma, S Misra, B Godman Expert review of clinical pharmacology 14 (1), 95-103, 2021 | 72 | 2021 |
| Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database J Charan, S Dutta, R Kaur, P Bhardwaj, P Sharma, S Ambwani, I Jahan, ... Expert opinion on drug safety 20 (9), 1125-1136, 2021 | 41 | 2021 |
| Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility A Sharma, A Singh, MA Dar, RJ Kaur, J Charan, K Iskandar, M Haque, ... Journal of Infection and Public Health 15 (2), 172-181, 2022 | 38 | 2022 |
| The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European, and South American countries; findings and implications for … B Godman, M Haque, T Leong, E Allocati, S Kumar, S Islam, J Charan, ... Frontiers in public health 9, 671961, 2021 | 38 | 2021 |
| Knowledge, awareness and practice of ethics among doctors in tertiary care hospital S Singh, PK Sharma, B Bhandari, R Kaur Indian journal of pharmacology 48 (Suppl 1), S89, 2016 | 36 | 2016 |
| Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study C Fotopoulou, T Khan, J Bracinik, J Glasbey, N Abu-Rustum, L Chiva, ... American Journal of Obstetrics & Gynecology 227 (5), 735. e1-735. e25, 2022 | 33 | 2022 |
| Analysis of neurological adverse events reported in VigiBase from COVID-19 vaccines S Dutta, R Kaur, J Charan, P Bhardwaj, SR Ambwani, S Babu, JP Goyal, ... Cureus 14 (1), 2022 | 32 | 2022 |
| Snapshot of COVID-19 related clinical trials in India J Charan, R Kaur, P Bhardwaj, T Kanchan, P Mitra, D Yadav, P Sharma, ... Indian Journal of Clinical Biochemistry 35, 418-422, 2020 | 29 | 2020 |
| Sample size calculation in medical research: a primer J Charan, R Kaur, P Bhardwaj, K Singh, SR Ambwani, S Misra Annals of the National Academy of Medical Sciences (India) 57 (02), 074-080, 2021 | 24 | 2021 |
| Ivermectin as adjuvant to hydroxycholoroquine in patients resistant to standard treatment for SARS-CoV-2: Results of an open-label randomized clinical study N Kishoria, SL Mathur, V Parmar, RJ Kaur, H Agarwal, BS Parihar, ... Paripex-Indian Journal Of Research 9 (8), 2020 | 23 | 2020 |
Dr Pankaj BhardwajProfessor, Community & Family Medicine, Academic Head, School of Public Health, Vice Dean Research在 aiimsjodhpur.edu.in 的电子邮件经过验证
